Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2020

Aguti Sara, Marrosu Elena, Muntoni Francesco, Zhou Haiyan

Abstract excerpt

Allele-specific gene silencing by antisense oligonucleotide (ASO) or small interference RNA (siRNA) has been used as a therapeutic approach for conditions caused by dominant gain-of-function mutations. We here present an antisense approach using gapmer ASO to diminish the dominant-negative effect in Ullrich congenital muscular dystrophy (UCMD) caused by dominant mutation in one of the COL6A genes. We provide the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Collagen Type VI
Share to Fluorescent Antibody Technique

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Dominant

Share to Genetic Therapy

Share to Muscular Dystrophies

Share to Oligonucleotides

Share to Real-Time Polymerase Chain Reaction

Share to Sclerosis

Source

Identifiers

PMID: 32865794
DOI: 10.1007/978-1-0716-0771-8_16

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy.PMID 32865794Read ↗

Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular DystrophySemantic proximity Read ↗

Personalized allele-specific antisense oligonucleotides for GNAO1-neurodevelopmental disorderSemantic proximity Read ↗

Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.Semantic proximity Read ↗

Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model.Semantic proximity Read ↗

Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophySemantic proximity Read ↗

Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMDSemantic proximity Read ↗

Developing Therapeutic Splice-Correcting Antisense Oligomers for Adult-Onset Pompe Disease with c.-32-13T>G Mutation.Semantic proximity Read ↗

GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle CellsSemantic proximity Read ↗

Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe DiseaseSemantic proximity Read ↗

Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic miceSemantic proximity Read ↗

Pre-mRNA Splicing Modulation by Antisense Oligonucleotides.Semantic proximity Read ↗

Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.